# Assessing Ketorolac (Toradol) at Oocyte Retrieval

> **NCT06026553** · PHASE1 · UNKNOWN · sponsor: **Shady Grove Fertility Reproductive Science Center** · enrollment: 400 (estimated)

## Conditions studied

- Infertility
- Infertility, Female
- Oocyte Retrieval
- Postoperative Pain
- Embryo Transfer

## Interventions

- **DRUG:** Ketorolac (Toradol)
- **OTHER:** Placebo (saline)

## Key facts

- **NCT ID:** NCT06026553
- **Lead sponsor:** Shady Grove Fertility Reproductive Science Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-10
- **Primary completion:** 2023-12
- **Final completion:** 2025-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2023-09-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06026553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06026553, "Assessing Ketorolac (Toradol) at Oocyte Retrieval". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06026553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*